Advances in Prostate Cancer Chemotherapy: A New Era Begins.

The article focuses on two hallmark studies that demonstrates a survival advantage in androgen-independent prostate cancer patients utilizing docetaxel chemotherapy in the U.S. Multiple mechanisms of androgen independence have now been documented including amplification of the androgen receptor as well as signal transduction pathways that bypass the androgen receptor completely.